Arrow-right Camera

The Spokesman-Review Newspaper The Spokesman-Review

Sunday, March 29, 2020  Spokane, Washington  Est. May 19, 1883
Partly Cloudy Day 57° Partly Cloudy


Everything tagged

Sort by:

Stories tagged: pharmaceutical companies

Trump falls short in CEO roundtable on coronavirus vaccine

As a private citizen and presidential candidate, Donald Trump was a proponent of vaccine skepticism - ignoring the scientific consensus on stuff like how vaccines don’t cause autism. As president, …

Swinomish tribe files lawsuit against drug companies

The Swinomish Indian Tribal Community has joined the ranks of governmental organizations filing lawsuits against large pharmaceutical companies.

UPDATED: Fri., May 11, 2018

Trump’s prescription to reduce drug prices takes small steps

President Donald Trump’s long-awaited plan to bring down drug prices, unveiled Friday, will mostly spare the pharmaceutical industry he previously accused of “getting away with murder” and instead focus on …

Tribes sue drug companies over opioid crisis

The Port Gamble S’Klallam, Suquamish and the Jamestown S’Klallam tribes have a lawsuit against pharmaceutical companies and drug distributors claiming the companies flooded their reservations with deadly opioids.

FDA’s war on pricey drugs a good start

The FDA’s power to reduce the price of prescription drugs is limited, but its campaign to use generics to foster greater competition deserves wide support.

UPDATED: Thu., April 13, 2017

Two companies seek to prevent drugs’ use in Arkansas executions

Two pharmaceutical companies asked a federal judge Thursday to prevent Arkansas from using their drugs to execute seven inmates by the end of the month, saying they object to their …

Legislation needed to curb drug-price hikes

Recent legislation in the U.S. Senate and in the Washington Legislature may eventually shine a brighter light on pricing practices.

Tough talk won’t lower drug prices

If prices don’t come down, and quickly, Trump should back up his tough talk with action.

Consumer Confidential: How a $500 copay turned into a $3,900 bill

Price gouging in the specialty drug market underlines the craziness of the U.S. health care system, which encourages people to take personal responsibility for their well-being but denies them the …

Court: ’pay to delay’ generic drugs can be illegal

WASHINGTON — The Supreme Court says deals between pharmaceutical corporations and their generic drug competitors, which government officials say keep cheaper forms of medicine off the market, can sometimes be …